Biochemistry, Genetics and Molecular Biology
ABC Transporter
7%
ABCG2
12%
Allele
24%
ATP-binding Cassette Transporter
7%
Candidate Gene
23%
Carcinogenesis
14%
Case-Control Study
16%
Cohort Study
35%
Colon
20%
Enzyme
9%
Feces microflora
6%
Gene Expression
10%
Gene Polymorphism
7%
Genetic Architecture
8%
Genetic Determinism
8%
Genetic Divergence
30%
Genetic Marker
10%
Genetic Polymorphism
7%
Genetic Risk
16%
Genetic Variation
9%
Genetics
33%
Genome Wide Association Study
6%
Genome-Wide Association Study
37%
Genotyping
19%
IL1B
10%
Intestine Flora
9%
Lifestyle
6%
Messenger RNA
15%
NFKB1
11%
NLR Family Pyrin Domain containing 3
7%
P-Glycoprotein
8%
Patient Registry
6%
Pattern Recognition Receptor
7%
Proteome
10%
Proteome Analysis
9%
Proteomics
21%
Single Nucleotide Polymorphism
12%
Single-Nucleotide Polymorphism
41%
T Cell
7%
T Cell Receptor
6%
TLR 1
8%
TLR2
9%
TLR4
14%
TLR5
9%
TNF Inhibitor
7%
TNFRSF1A
7%
Toll-Like Receptor
10%
Transcriptome
6%
Tumor Necrosis Factor
47%
Tumor Necrosis Factor Alpha
6%
Immunology and Microbiology
ABCG2
6%
Allele
16%
Biological Product
8%
Colitis
9%
Colon
11%
Crohn's Disease
44%
DNA Polymorphism
11%
Drug Metabolism
5%
Drug Response
5%
Enteritis
5%
Feces microflora
6%
First Pass Effect
5%
Gene Expression
11%
Genetic Marker
6%
Genetic Variability
12%
Genetic Variation
9%
IL1B
8%
Inflammation Response
5%
Inflammatory Arthritis
46%
Inflammatory Bowel Disease
99%
Inflammatory Disorder
16%
Interleukin 18
6%
Intestine Flora
13%
Microflora
6%
Monozygotic Twins
6%
Morphology
6%
Mucosa
7%
Multidrug Resistance
6%
Multiple Myeloma
17%
Neutrophil Extracellular Traps
6%
Normal Human
8%
P-Glycoprotein
7%
Pattern Recognition Receptor
8%
Progeny
5%
Proteome Analysis
11%
Psoriatic Arthritis
17%
Signal Transduction
5%
Single Nucleotide Polymorphism
27%
T Cell Receptor
6%
TLR 1
5%
TLR2
9%
TLR4
13%
TLR5
7%
TLR9
5%
TNF Inhibitor
10%
TNFRSF1A
6%
Toll-Like Receptor
7%
Tumor Necrosis Factor
49%
Tumor Necrosis Factor Alpha
10%
Ulcerative Colitis
53%
Medicine and Dentistry
ABC Transporter Subfamily B
7%
Biological Marker
12%
Biological Product
10%
Biological Therapy
11%
Breast Cancer Resistance Protein
6%
Carcinogenesis
6%
Coeliac Disease
6%
Cohort Analysis
12%
Colorectal Cancer
13%
Combination Therapy
7%
Crohn's Disease
36%
Diabetes Mellitus
6%
Diagnosis
6%
Disease
35%
Disease Course
13%
Drug Therapy
8%
Emergency Department
6%
Fecal Microbiota Transplantation
10%
Gastroenteritis
6%
Gene Expression
6%
Genome Wide Association Study
14%
Genotype
7%
Gut
7%
Health Care Cost
7%
Hormone Receptor
6%
Immunomodulating Agent
7%
Inflammatory Bowel Disease
100%
Inflammatory Disorder
26%
Maintenance Therapy
7%
Meta-Analysis
10%
Neutrophil
6%
Patient with Crohn's Disease
10%
Patient with Inflammatory Bowel Disease
21%
Patient with Ulcerative Colitis
6%
Personalized Medicine
9%
Placebo
15%
Prognostic Factor
6%
Prospective Cohort Study
10%
Psoriasis
7%
Psoriatic Arthritis
13%
Rheumatoid Arthritis
28%
Single Nucleotide Polymorphism
13%
Systematic Review
14%
TNF Inhibitor
9%
Treatment Response
13%
Tumor Necrosis
8%
Tumor Necrosis Factor
16%
Ulcerative Colitis
47%
Vedolizumab
6%
Vitamin D
6%
